ArticleEuropean journal of nuclear medicine and molecular imaging2021
Clinical insignificance of [
Article in European journal of nuclear medicine and molecular imaging, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
49 citing papers in PubMed, 3 syntheses or guidelines pooled it, 79 citations in OpenAlex.
- Comparison ofProstate cancer and prostatic diseases · 2024Pooled it
- The Homunculus of unspecific bone uptakes associated with PSMA-targeted tracers: a systematic review-based definition.European journal of nuclear medicine and molecular imaging · 2024Pooled it
- Pooled it
- Development and validation of a preoperativeEuropean journal of nuclear medicine and molecular imaging · 2026Article
- A computer-aided diagnosis tool in prostate cancer patients with biochemical recurrence using 18F-PSMA PET/CT imaging.Medical physics · 2026Article
- Methodological and clinical considerations on predicting PSMA-positive metastatic disease in early biochemical failure after radical prostatectomy: Comment on Santo et al.Annals of nuclear medicine · 2026Article
- Evaluating indeterminate bone lesions and lymph nodes on PSMA-PET: a multidisciplinary consensus algorithm and 1-year implementation results.European radiology · 2026Article
- Multidisciplinary team interpretation performance for indeterminate bone uptake on PSMA PET during prostate cancer staging: Comparison with PROMISE criteria.European journal of nuclear medicine and molecular imaging · 2026Article
- Article
- Context-level machine learning to improve the identification of lymph node and bone metastases in prostate cancer patients using [EJNMMI physics · 2025Article
- Review
- The role of PSMA PET/CT in distinguishing malignant from benign solitary bone lesions in prostate cancer patients.Clinical imaging · 2025Article
- PSMA-avid rib lesions in prostate cancer patients: differentiating false positives from metastatic disease.European radiology · 2025Article
- PSMA PET Imaging in the Management of Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Radioligand Therapy.Targeted oncology · 2025Review
- Unspecific bone uptakes in PSMA PET for prostate cancer: why do they matter?European radiology · 2025Article
- PSMA PET/CT for prostate cancer diagnosis: current applications and future directions.Journal of cancer research and clinical oncology · 2025Review
- [European journal of nuclear medicine and molecular imaging · 2025Article
- How Does Routine Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Modify the Current Management of Prostate Cancer? A Multidisciplinary View.European urology open science · 2025Article
- Comparison of early and standardAnnals of nuclear medicine · 2025Article
- Exploring the Correlation Between Multiparameters Detected in Primary Prostate Cancer using F‑18 PSMA‑1007 PET/MRI and their Potential for Predicting Metastasis.Nuclear medicine and molecular imaging · 2025Article
Corrections and comments
- Commented on by
Authors and funding
9 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purpose[
methodsA retrospective audit of 214 men with prostate cancer was performed to investigate the clinical outcomes of [
resultsNinety-four of 214 patients (43.9%) demonstrated at least one NSBL. No [
conclusion[
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.